Solazyme Inc. (NASDAQ:TVIA) will be issuing its quarterly earnings data after the market closes on Thursday, July 28th. Analysts expect the company to announce earnings of ($0.29) per share for the quarter.
Solazyme (NASDAQ:TVIA) last issued its quarterly earnings results on Wednesday, May 4th. The company reported ($0.27) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.29) by $0.02. The company earned $10.90 million during the quarter, compared to analyst estimates of $11.94 million. During the same quarter last year, the firm earned ($0.37) EPS. The business’s revenue was down 13.5% on a year-over-year basis. On average, analysts expect Solazyme to post $-1.12 EPS for the current fiscal year and $-0.98 EPS for the next fiscal year.
In related news, CFO Tyler Painter sold 12,500 shares of the company’s stock in a transaction on Tuesday, June 7th. The shares were sold at an average price of $2.67, for a total transaction of $33,375.00. Following the completion of the sale, the chief financial officer now directly owns 400,337 shares of the company’s stock, valued at approximately $1,068,899.79. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.
Solazyme, Inc creates renewable oils and bioproducts. The Company’s technology uses microalgae in an industrial fermentation process to transform a range of plant-based sugars into triglyceride oils and other bioproducts. The Company offers Algenist, a skin and personal care product available at Sephora SA and its affiliates, QVC, Inc, SpaceNK Limited, select Nordstrom stores and ULTA Beauty.
